Biodel Inc (NASDAQ:BIOD)

Data as of 3:59pm ET
 +0.02 / +1.21%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Biodel, Inc. is a specialty pharmaceutical company that develops novel formulations of already approved therapeutics to treat endocrine disorders such as diabetes and osteoporosis. It is developing novel forms of insulin and other peptide hormones for use in treating diabetes and its complications, including hyperglycemia, hypoglycemia, cardiovascular complications and weight control. Biodel was founded by Solomon S. Steiner and Erik Steiner on December 3, 2003 and is headquartered in Danbury, CT.

Contact Information

Biodel, Inc.
100 Saw Mill Road
Danbury Connecticut 06810
P:(203) 796-5000
Investor Relations:



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Errol B. De SouzaPresident, Chief Executive Officer & Director
Erik SteinerVice President-Operations
Gary G. GemignaniChief Financial Officer
Alan Seth KrasnerChief Medical Officer
Paul S. BavierSecretary & Chief Compliance Officer

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.